We serve Chemical Name:2-(Trifluoromethyl)quinoline-4-carboxylicacid CAS:18706-39-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(Trifluoromethyl)quinoline-4-carboxylicacid
CAS.NO:18706-39-3
Synonyms:2-(Trifluoromethyl)quinoline-4-carboxylicacid;2-trifluoromethyl cinchoninic acid;2-(Trifluoromethyl)quinoline-4-carboxylic acid;2-trifluoromethyl-quinoline-4-carboxylic acid;4-Quinolinecarboxylic acid, 2-(trifluoromethyl)-;2-(Trifluoromethyl)-4-quinolinecarboxylic acid;2-Trifluormethyl-chinolyl-(4)-carbonsaeure;CC-PMLSC-DMA-P114;2-trifluoromethyl-4-quinoline carboxylic acid
Molecular Formula:C11H6F3NO2
Molecular Weight:241.166
HS Code:2933499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:323.7±42.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.579
PSA:50.19000
Exact Mass:241.035065
LogP:3.45
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(Trifluoromethyl)quinoline-4-carboxylicacid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-trifluoromethyl-4-quinoline carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-trifluoromethyl-quinoline-4-carboxylic acid Use and application,2-(Trifluoromethyl)quinoline-4-carboxylicacid technical grade,usp/ep/jp grade.
Related News: These sites operate under cGMP conditions and have been inspected and approved by leading global pharmaceutical companies and regulatory authorities, including the US FDA. N-dodecyl-3,4,5-trihydroxybenzamide manufacturers The $672 million raised in the listing will go toward expanding Stevanato’s factories in Italy and China and building a new plant for vials, syringes and cartridges in Fishers, Indiana—sweetened by $2.9 million in conditional tax credits from the state—that’s expected to bring more than 200 jobs to the area. (E)-1,2-bis((4-chlorotetrahydro-2H-pyran-4-yl)methyl)diazene 1,2-dioxide suppliers Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” (4-bromophenyl)-[4-(1,3-dioxolan-2-yl)phenyl]methanone vendor & factory.
